BioSpace News Archive

Anavex Life Sciences Corp. announced that Anavex Management Team will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 3:45 PM ET.

ProMIS Neurosciences Inc., is pleased to announce it has mailed the Notice of Notice-and-Access to shareholders of record of the Corporation as of April 01, 2022, in connection with the Annual General and Special Meeting of the Shareholders of the Corporation to be held Thursday, May 12, 2022, at 9:00 a.m.

XORTX Therapeutics Inc. is pleased to announce receipt of notification that the patent “Formulations of Xanthine Oxidase Inhibitors” will be granted by the United States Patent Office (USPTO).

Aptose Biosciences Inc. today announced the appointment of Mr. Philippe Ledru to the position of Chief Commercial Officer.

Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International Research Society (SIRS), taking place April 6-10, 2022 in Florence, Italy.

CytoSorbents Corporation today announced that it has received approximately $740,000, net of transactions costs.

Click Therapeutics, Inc today announced that Randall Stanicky, Chief Financial Officer, will present at Chardan’s Prescription Digital Therapeutics Summit on Monday, April 11, 2022 at 2:30 p.m. ET.

Vizgen today announced that it will be presenting a poster at the 2022 American Association for Cancer Research (AACR) Annual Meeting.

Moderna, Inc. today announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health threats.

VectivBio Holding AG today reported financial results and provided a business update for the full year ended December 31, 2021.